Aleksandar J Dimovski
Overview
Explore the profile of Aleksandar J Dimovski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonato A, Chakraborty S, Bomben R, Canarutto G, Felician G, Martines C, et al.
Leukemia
. 2024 Mar;
38(7):1511-1521.
PMID: 38486128
Loss-of-function mutations in NFKBIE, which encodes for the NF-κB inhibitor IκBε, are frequent in chronic lymphocytic leukemia (CLL) and certain other B-cell malignancies and have been associated with accelerated disease...
2.
Martines C, Chakraborty S, Vujovikj M, Gobessi S, Vaisitti T, Deaglio S, et al.
Blood
. 2022 Sep;
140(22):2335-2347.
PMID: 36084319
A large amount of circumstantial evidence has accumulated suggesting that Toll-like receptor (TLR) signals are involved in driving chronic lymphocytic leukemia (CLL) cell proliferation, but direct in vivo evidence for...
3.
Palles C, West H, Chew E, Galavotti S, Flensburg C, Grolleman J, et al.
Am J Hum Genet
. 2022 Apr;
109(5):953-960.
PMID: 35460607
We report an autosomal recessive, multi-organ tumor predisposition syndrome, caused by bi-allelic loss-of-function germline variants in the base excision repair (BER) gene MBD4. We identified five individuals with bi-allelic MBD4...
4.
Chakraborty S, Martines C, Porro F, Fortunati I, Bonato A, Dimishkovska M, et al.
Blood
. 2021 Apr;
138(12):1053-1066.
PMID: 33900379
B-cell receptor (BCR) signals play a critical role in the pathogenesis of chronic lymphocytic leukemia (CLL), but their role in regulating CLL cell proliferation has still not been firmly established....
5.
Kapedanovska-Nestorovska A, Dimovski A, Sterjev Z, Matevska Geskovska N, Suturkova L, Ugurov P, et al.
Pharmgenomics Pers Med
. 2019 Nov;
12:287-295.
PMID: 31695473
Aims: The present observational cohort study evaluated the association between the (rs1872930) allele and the risk of major adverse cardiovascular and cerebrovascular events (MACCE) in clopidogrel treated patients. Methods: We...
6.
Grolleman J, de Voer R, Elsayed F, Nielsen M, Weren R, Palles C, et al.
Cancer Cell
. 2019 Feb;
35(2):256-266.e5.
PMID: 30753826
Biallelic germline mutations affecting NTHL1 predispose carriers to adenomatous polyposis and colorectal cancer, but the complete phenotype is unknown. We describe 29 individuals carrying biallelic germline NTHL1 mutations from 17...
7.
Panovska-Stavridis I, Ivanovski M, Trajkova S, Pivkova-Veljanovska A, Popova-Labaceska M, Matevska-Geshovska N, et al.
Pril (Makedon Akad Nauk Umet Odd Med Nauki)
. 2018 Apr;
38(3):157-162.
PMID: 29668469
Myelodysplastic syndrome (MDS) is a diverse group of clonal hematologic neoplasms. The only curative treatment for MDS is allogeneic stem cell transplantation (SCT). Epigenetic changes play an important role in...
8.
Ballazhi L, Imeri F, Jashari A, Popovski E, Stojkovic G, Dimovski A, et al.
Acta Pharm
. 2017 Feb;
67(1):35-52.
PMID: 28231049
This study evaluates the effects of previously synthesized hydrazinyldiene-chroman-2,4-diones on cell proliferation and apoptosis, cell cycle distribution and migration capacity of MCF-7 breast cancer cells in synergy with doxorubicin. Physicochemical...
9.
Panovska-Stavridis I, Eftimov A, Ivanovski M, Stojanovic A, Georgievski B, Cevreska L, et al.
Clin Lymphoma Myeloma Leuk
. 2016 Aug;
16(8):477-81.
PMID: 27521277
Background: Acquired calreticulin (CALR) gene mutations are one of the molecular hallmarks of essential thrombocythemia (ET). It has been suggested that patients with ET with CALR mutations are associated with...
10.
Panovska-Stavridis I, Eftimov A, Ivanovski M, Pivkova-Veljanovska A, Cevreska L, Hermouet S, et al.
Clin Lymphoma Myeloma Leuk
. 2016 Mar;
16(5):e55-7.
PMID: 27009537
No abstract available.